BWF Provides Support for Scientists Conducting Research in Regulatory Science

RESEARCH TRIANGLE PARK, NC – The Burroughs Wellcome Fund is pleased to announce the inaugural class of the Innovation in Regulatory Science Award.  The award provides up to $500,000 over five years to academic investigators who are addressing research questions that will lead to innovation in regulatory science, with ultimate translation of those results into improving the regulatory process.

Food and Drug Administration defines regulatory science as the “development and use of new tools, standards, and approaches to more efficiently develop products and to more effectively evaluate product safety, efficacy, and quality”.  It is has become the centerpiece of the FDA’s strategy to foster innovation and the agency has called on the academic and foundation communities to take an active role in building this emerging field.

This initiative of the Burroughs Wellcome Fund is focused on providing support for academic researchers developing new methodologies or innovative approaches in regulatory science that will ultimately inform regulatory decisions.

“Regulatory science is not a high profile research area,” said BWF President Dr. John Burris.  “But the results have the potential to make an enormous impact”. 

The 2013 recipients of the Innovation in Regulatory Science Award are:

Dana V. Devine, Ph.D.
Canadian Blood Services
Refreshing the regulatory approach to ensuring the safety and efficacy of blood transfusion products

Kathleen M. Giacomini, Ph.D.
University of California-San Francisco
Systems pharmacology approaches to understanding drug-induced weight gain

Alison H. Harrill, Ph.D.
University of Arkansas for Medical Sciences
Advancing regulatory science through translational pharmacogenomics

Calum A. MacRae, M.B. Ch.B., Ph.D.
Brigham and Women’s Hospital/Harvard Medical School
Building structure-related prediction algorithms for organ-specific drug toxicity through iterative modeling in novel zebrafish reporter lines

Vishal S. Vaidya, Ph.D.
Brigham and Women’s Hospital
Mapping the biology of a damaged kidney cell

Susan W. Yackee, Ph.D.
University of Wisconsin-Madison
When politics intrudes on science: regulatory policymaking at the FDA

###